TrialPanorama/TrialPanorama-database huggingface dataset:
Study: NCT06197230

Intervention type: OTHER
Group type: OTHER
Intervention: Drawing Intervention
Description: The primary sections of Drawing Intervention will be the art-making and art-sharing sections. During the art-making segment, the group leader will guide the participants through a paper-warming exercise before assigning them a specific subject to draw freely for 20-30 minutes. The leader will then ask participants to talk about the meaning of their artwork, encouraging them to explore their emotions regarding the theme and their drawing. This procedure will be implemented in each segment of the intervention (6 sessions).

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Drawing Intervention
Description: The primary sections of Drawing Intervention will be the art-making and art-sharing sections. During the art-making segment, the group leader will guide the participants through a paper-warming exercise before assigning them a specific subject to draw freely for 20-30 minutes. The leader will then ask participants to talk about the meaning of their artwork, encouraging them to explore their emotions regarding the theme and their drawing. This procedure will be implemented in each segment of the intervention (6 sessions).
Study: NCT03850730

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Pazopanib
Description: Active pharmaceutical ingredient plus excipients filled into a capsule for the lower dosing necessary in this study
Study: NCT04721379

Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Meditation
Description: 1. Group 1 participants with unguided session simply close their eyes for 10 minutes while EEG and EKG recordings are performed. Following 10 minutes, after briefly opening their eyes, they will be asked to relax with eyes closed for 30 minutes. After finishing the session, they fill out meditation depth questionnaire.~2. Group 2 participants with guided sessions close their eyes for 10 minutes while EEG and EKG recordings are performed. Following 10 minutes, after briefly opening their eyes, they will be guided through relaxation and meditation session for 30 minutes with a Heartfulness trainer with continued recording. After finishing the session, they also fill out meditation depth questionnaire.

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Meditation
Description: 1. Group 1 participants with unguided session simply close their eyes for 10 minutes while EEG and EKG recordings are performed. Following 10 minutes, after briefly opening their eyes, they will be asked to relax with eyes closed for 30 minutes. After finishing the session, they fill out meditation depth questionnaire.~2. Group 2 participants with guided sessions close their eyes for 10 minutes while EEG and EKG recordings are performed. Following 10 minutes, after briefly opening their eyes, they will be guided through relaxation and meditation session for 30 minutes with a Heartfulness trainer with continued recording. After finishing the session, they also fill out meditation depth questionnaire.
Study: NCT05032365

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Close-loop FiO2 controller
Description: Close-loop FiO2 controller software option provides automated adjustment of the ventilator Oxygen setting to maintain the patient's SpO2 in a defined target range. When using the software option, the user defines the SpO2 target range, as well as the SpO2 emergency limits, and the device adjusts the FiO2 setting to keep the patient's SpO2 in the target range.

Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Conventional
Description: Conventional FiO2 adjustment by the clinician according to SpO2 values
Study: NCT05340959

Intervention type: DEVICE
Intervention: Devices: Osstell®, Periotest® and AnyCheck®.
Description: 1. Osstell®: is a device that measure implant stability and based on resonance frequency analysis (RFA). Due to stiffness in the interface between the implant surface and the bone smart peg will vibrates accordingly. the more dense bone the higher stability, the higher frequency and higher Implant Stability Quotient (ISQ) value which is from 1-100.~2. Periotest®: is a device used to assess osseointegration of dental implants, so it measure implant stability . it is based on damping effect of implant. Showing the measurement digitally on a scale from -8 (low mobility) to 50 (high mobility) PTV units.~3. AnyCheck®: this is an implant stability meter that measures the stiffness of alveolar bone-implant interface through a tapping motion. Showing the measurement on a scale from 30 (low stability) to 85 (high stability).
Study: NCT05287555

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Telemonitoring Care
Description: NIV, Supplies as needed, especially masks, tubes, humidifiers, SpO2 sensor and modems.

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Standard Care
Description: NIV, Supplies as needed, especially masks, tubes, humidifiers, and modems
Study: NCT04452292

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Treatment Specific for Non-Small Cell Carcinoma/Adenocarcinoma
Description: Treatment assigned to targetable mutation. Or, for tumors that are by and large without any targetable mutation follow Large-Cell Neuroendocrine Carcinoma (NCCN) guideline-directed best front-line treatment for specific non-small cell carcinoma/adenocarcinoma.

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Treatment for Small Cell Lung Cancer
Description: Treatment assigned to a targetable mutation or the current standard-of-care regimen for the treatment of small cell lung cancer.
Study: NCT05147948

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: iACT for PTSD and Chronic Pain
Description: The participants will go through internet-based Acceptance and Commitment Therapy which mainly involves: 1) Exercises focused on developing acceptance, defusion, and mindfulness skills; 2) Identification of personal values as well as valued steps and feared situations to approach during the program 3) Written exposure exercises focusing on the traumatic memory adapted from Written exposure therapy (WET) using an ACT-based framework. The treatment is delivered on a safe internet platform. Participants have planned telephone contact with their assigned psychologist 3 times during the program and can also contact their psychologist via a message system in the platform and expect answer within 48 hours.
Study: NCT04751201

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Mindfulness open and circular program
Description: At the end of the first and the last cycle, as well as 3 weeks after the last cycle, the patient will be invited to answer different questionnaires evaluating his or her quality of life (HADS, QLQC30, FA12). This is why the observation period is 3 months (3 cycles of 3 weeks + 3 weeks).~Similarly, some of the patients included in the study will be asked to complete a semi-structured interview at the end of the MAEva programme.~Patients and nursing staff participating in the study will be asked to complete a satisfaction questionnaire
Study: NCT06427655

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: SALAD intubation
Description: SALAD suction during intubation
Study: NCT05147610

Intervention type: DIAGNOSTIC_TEST
Group type: EXPERIMENTAL
Intervention: Intraocular pression
Description: First, measurement of the eye pressure by air-puff tonometry and estimation of the pachymetries with the TONOREF III.~Secondly, measurement of the eye pressure by GAT. Thirdly, measurement of the eye pressure by Icare 200.
Study: NCT06580366

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Sennosid A+B
Description: Bowel Preparation

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Sodium Picosulfate/Magnesium Oxide/Citric Acid
Description: Bowel Preparation
Study: NCT04850430

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Gastric venous reconstruction
Description: Patients will be assigned to study after intraoperative evaluation of gastric venous drainage after coronary vein resection during TP, and the gastric venous outflow will be reconstructed after TP.
Study: NCT05182710

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Stress Inoculation Training
Description: The SIT programme/intervention will involve~1. 30 minute educational phase of preparatory information to allow participants to conceptualise the types of stressors they are likely to face and the role of stress on performance~2. 30 minutes of skills acquisition which will involve discussion of and teaching participants techniques to reduce stress in simulated resuscitation events~3. Inoculation through the application of acquired skills in 1-2 resuscitation scenarios
Study: NCT06579456

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Surgical Training Intervention
Description: Validation of a Formaldehyde-Free embalmed cadavers for recreate with more precision the experience of learning surgical endoscopy

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Positive Control
Description: training in models that emulate the rigidity, structure, dimensions, and haptic feedback of the anatomical structures to be treated.

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Negative Control
Description: Training proceeded in the rigid described skills acquisition platform, adding suture training using a perforable MMA-type woven fabric
Study: NCT05605054

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: UCSD RELINK
Description: UCSD RELINK coach-guided health literacy intervention and in-person service navigation assistance

Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Self-study
Description: Self-studying of programmatic information and list of service referrals
Study: NCT06465420

Intervention type: BIOLOGICAL
Group type: PLACEBO_COMPARATOR
Intervention: Haemophilus influenzae type a (Hia) glycoconjugate vaccine
Description: 0.5 mL intramuscular injection, given on days 0 and 28

Intervention type: BIOLOGICAL
Group type: ACTIVE_COMPARATOR
Intervention: Haemophilus influenzae type a (Hia) glycoconjugate vaccine
Description: 0.5 mL intramuscular injection, given on days 0 and 28
Study: NCT05344534

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Leadership and Organizational Change for Implementation
Description: LOCI is data driven leadership development and coaching for clinic managers and working with agency executives and middle managers to foster a strategic implementation climate
Study: NCT06116565

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: CM310
Description: CM310, subcutaneous injection
Study: NCT04867356

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Spinal Stabilization Exercises (SSE)
Description: Spinal stabilization exercises (SSE) including bridging, planks and tummy tuck-in will be performed. Each participant received a total 7 session thrice a week sessions in two weeks, . Each session had lasted for 30-40 minutes. Spinal stabilization exercises were repeated 5-15 times depending on the endurance of patients.~Home exercise plan will also be given e.g. postural care, precautions in lifting and carrying weights etc.

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Spinal Stabilization Exercises (SSE) & Latissimus Dorsi Stretching (LDS)
Description: In experimental group in addition SSE group interventions, participants will receive the latissimus dorsi stretching (LDS). Each participant received a total 7 session thrice a week sessions in two weeks. Each session had lasted for 30-40 minutes. each stretch of latissimus dorsi was of 20-30 seconds with 10-20 repetitions in each session.
Study: NCT05461703

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Planet Nutrition Program
Description: It is a 6-month school-based obesity prevention program that includes: nutrition education sessions, physical activity and family participation.

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Planet Nutrition Program
Description: It is a 6-month school-based obesity prevention program that includes: nutrition education sessions, physical activity and family participation.
Study: NCT05135416

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: chewing gum Group
Description: control of consciousness chewing gum listening to bowel sounds assessment of pain

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Control group
Description: control of consciousness listening to bowel sounds assessment of pain
Study: NCT05138445

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: FAME-W self-management intervention
Description: FAME-W is an occupational therapy led, four-week group based self-management intervention. It focuses on providing people with IA skills and confidence to manage demands of their employment and daily life through education on IA, self-management techniques, managing symptoms of fatigue, pain and stress and managing physical and mental health.

Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: FAME-W Handbook
Description: Individuals in this arm receive a self-guided FAME-W handbook containing the same information as that covered in the four week FAME-W program
Study: NCT04936191

Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: DynamX Bioadaptor
Description: Patients received percutaneous coronary intervention in a similar way to a traditional DES. Patients first receive radial artery or femoral artery cannulation with anticoagulation during the intervention. All coronary angiograms are carefully measured by at least 2 orthographic views and performed under the same standard conditions. After adequate predilatation of the target lesion, the coronary stenting will be performed. All patients will receive a loading dose of acetylsalicylic acid and a P2Y12 inhibitor pre-procedure followed by dual antiplatelet therapy for at least 6 months.

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: DynamX Bioadaptor
Description: Patients received percutaneous coronary intervention in a similar way to a traditional DES. Patients first receive radial artery or femoral artery cannulation with anticoagulation during the intervention. All coronary angiograms are carefully measured by at least 2 orthographic views and performed under the same standard conditions. After adequate predilatation of the target lesion, the coronary stenting will be performed. All patients will receive a loading dose of acetylsalicylic acid and a P2Y12 inhibitor pre-procedure followed by dual antiplatelet therapy for at least 6 months.
Study: NCT06459648

Intervention type: OTHER
Intervention: Headache record
Description: The patient will keep a record of the presence/absence of headache, average intensity, and need for acute medication.

Intervention type: OTHER
Intervention: Scales
Description: Each patient performs different scales that measure the impact of the migraine on their daily life as well as the disability it may be causing. In turn, each patient performs different scales that measure associated comorbidities such as depression, anxiety or insomnia.

Intervention type: DRUG
Intervention: Monoclonal antibody anti-CGRP
Description: Erenumab, Galcenazumeb, Fremanezumab, Eptinezumab
Study: NCT05670483

Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Use Of APRV mode of Ventilation
Description: Post operatively, Patients will be ventilated with APRV mode using GE Carescape R860 ventilator Initial Settings15~1. P high at the P plateau (or desired P mean + 3cm H2O). keep P high below 30-35 cm H2O~2. T high at 4-6 seconds~3. P low at 0~4. T low at 0.5 to 0.8 seconds.~5. ATC (automatic tube compensation) on.~6. FIO2: 40% Ventilator settings will be adjusted to keep Pco2 between 35-45 mmhg, PO2 \> 60 mmhg on FIO2 \< 50 % Once Patients are fully conscious and after complete recovery of reflexes with no postoperative bleeding nor hemodynamic instability, weaning of APRV will start as following, P-High will be lowered 2 or 3 cm of H2O pressure at a time, and T Low will be lengthened in 0.5-2.0 s increments, depending on patient tolerance. When the P-high reaches 10 cmH2O and the Thigh reaches 12-15 seconds, change the mode to pressure support (PS) mode PS of 7-8 cmH20 above PEEP of cmh2o then extubation.

Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Use of conventional Synchronized Intermittent Mandatory Ventilation (SIMV) volume control mode
Description: Post-operatively, Patients will be ventilated with conventional Synchronized Intermittent Mandatory Ventilation (SIMV) volume control mode using GE Carescape R860 ventilator Initial Settings: 16~1. Tidal Volume 6-8 ml/kg predicted body weight~2. Respiratory rate (RR) 14 /min~3. Positive end expiratory pressure (PEEP)= 5 cmH2o~4. Pressure Support (PS) = 10 cmH2o~5. Inspiratory time 1.4 Sec~6. FIO2: 40% Ventilator settings will be adjusted to keep Pco2 between 35-45 mmhg, PO2 \> 60 mmhg on FIO2 \< 50 % Once Patients are fully conscious and after complete recovery of reflexes with no postoperative bleeding nor hemodynamic instability, weaning of mechanical ventilation will be done by switching the ventilation to pressure support (PS) mode PS of 7-8 cmH20 above PEEP of cmh2o then extubation.
Study: NCT03130127

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Terlipressin
Description: According to the current practice guidelines and consensus, terlipressin is the standard treatment option for acute variceal bleeding in liver cirrhosis.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Terlipressin
Description: According to the current practice guidelines and consensus, terlipressin is the standard treatment option for acute variceal bleeding in liver cirrhosis.
Study: NCT06452810

Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Experimental: Sahajan Golden Glow Balm
Description: Participants will apply the Sahajan Golden Glow Balm twice daily (morning and night) to the periorbital area following the specified instructions.
Study: NCT06177678

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: TFC-003
Description: 1 drop of TFC-003 ophthalmic solution twice a day for 4 weeks.

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: COSOPT ophthalmic solution
Description: 1 drop of TFC-003 ophthalmic solution twice a day for 4 weeks.
Study: NCT05182710

Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Alternative Training
Description: 1. 30 minutes of teaching on management of a drowning patient (in order that both control and intervention perceive they have had teaching of the same length as the other group)~2. 1-2 resuscitation simulation events (same scenario and tasks as in the intervention group)
Study: NCT06358625

Intervention type: OTHER
Intervention: Pre-treatment biopsy
Description: A breast biopsy is performed just before the clip is placed in the tumour and additional blood samples are performed.
Study: NCT06129864

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: volrustomig
Description: volrustomig
Study: NCT05580848

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Wrist arthroscopy
Description: Wrist arthroscopy is a minimally invasive endoscopic method that enables the diagnosis and treatment of certain diseases and injuries of the radiocarpal, mediocarpal and distal radioulnar joints.~Wrist arthroscopy enables a direct view of the articular surface of the wrist and the assessment and adequate treatment of articular fractures The wrist arthroscopy procedure also enables the detection and necessary treatment of associated soft tissue injuries (scapho-lunate and/or luno-triquetral ligament, i.e. triangular fibrocartilaginous complex) and/or cartilage lesions in extra-articular and articular fractures.
Study: NCT06646302

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Low frequency burst sound stimulation
Description: Patients will be given low frequency burst sound stimulation at 10 dB above the threshold of the minimum masking level of tinnitus for a duration of 1 minute.
Study: NCT04906525

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Resistance training
Description: Participants will undergo 6 weeks of supervised resistance training

Intervention type: OTHER
Group type: OTHER
Intervention: Conventional physical activity guidelines
Description: Participants are given recommendations on physical activity guidelines
Study: NCT06326827

Intervention type: DEVICE
Intervention: In'Oss™ (MBCP® Putty)
Description: Use of In'Oss™ (MBCP® Putty) in surgical procedure to correct epiphyso-metaphyseal and/or metaphyso-diaphyseal bone defect in one of the following anatomical locations: Proximal humerus, Distal radius, Distal femur, Proximal tibia, Distal tibia.
Study: NCT06646302

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Tinnitus frequency-centered narrowband noise stimulation
Description: Patients will be given tinnitus frequency-centered narrowband noise stimulation at 10 dB above the threshold of the minimum masking level of tinnitus for a duration of 1 minute.
Study: NCT05769738

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Furosemide
Description: 40mg (4ml) of furosemide to be nebulized 3 times daily for 3 days

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Normal saline
Description: 4ml of normal saline to be nebulized 3 times daily for 3 days
Study: NCT05224258

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: MiniMed 780G System
Description: 780G System used with Insulin Fiasp® (Insulin Aspart Injection)
Study: NCT05332457

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Reduced dosage of beta-blocker
Description: Phase I:~1. CPET performed at trough BB concentration: participants will undergo CPET at least 30 hours after last beta-blocker usage.~2. CPET performed at peak BB concentration : participants will undergo CPET at 3 hours after last beta-blocker usage.~Phase II:~BB dosage will be reduced.

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Reduced dosage of beta-blocker
Description: Phase I:~1. CPET performed at trough BB concentration: participants will undergo CPET at least 30 hours after last beta-blocker usage.~2. CPET performed at peak BB concentration : participants will undergo CPET at 3 hours after last beta-blocker usage.~Phase II:~BB dosage will be reduced.
Study: NCT05527067

Intervention type: OTHER
Intervention: Data collection
Description: Neuropsychological assessment, brain MRI, electroencephalogram and biomarker datas will be collected

Intervention type: OTHER
Intervention: Data collection
Description: Neuropsychological assessment, brain MRI, electroencephalogram and biomarker datas will be collected
Study: NCT05637112

Intervention type: OTHER
Intervention: None (Observational study)
Description: Not Applicable since Observational Study